Amphastar Pharma (AMPH) Tops Q3 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Amphastar Pharma (AMPH) Tops Q3 EPS by 1c

Amphastar Pharmaceuticals (AMPH) PT Raised to $25 at Needham & Company

November 9, 2018 9:14 AM EST

Needham & Company analyst Serge Belanger raised the price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $25.00 (from $20.00) while maintaining a Buy rating.

Belanger commented, "AMPH delivered 3Q18 results that beat both top- and bottom-line Street consensus estimates, benefiting from a surprisising significant uptick in... More